Search
Search
Abnova
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Please note: We are reviewing Western blot images included in the antibody testing data in our catalog, including those provided by third parties. Unless expressly labeled or annotated as “raw-unedited”, Western blot images included in the antibody testing data in our catalog may have been edited, optimized or otherwise adjusted for presentation.
Product may be used with Sandwich ELISA (Recombinant protein).
Immunogen sequence: KPLWGVRLRL RPCNLAHAET LVIEIRDKED SSWQLFTVQV QTEAIGEGSL EPSPQSQAED GRSQAAVGAV PEGAWKDTAQ LHKSEEA
Neurodegenerative disorders such as Parkinson and Alzheimer disease cause motor and cognitive dysfunction and belong to a heterogeneous group of common and disabling disorders. ATP13A2, otherwise known as PARK9, is a neuronal P-type ATPase gene underlying an autosomal recessive form of early-onset parkinsonism with pyramidal degeneration and dementia. ATP13A2 protein is located in the membrane of these lysosomes and is formed most strongly in the brain, especially in the substantia nigra, a brain region which is known to play a central role in Parkinson's disease.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: AT132 antibody; ATPase 13A2; ATPase type 13A2; cation-transporting ATPase 13A2; HSA9947 antibody; probable cation-transporting ATPase 13A2; putative ATPase; RP1-37C10.4; unnamed protein product
基因别名: CLN12; HSA9947; KRPPD; PARK9; SPG78
UniProt ID: (Human) Q9NQ11
Entrez Gene ID: (Human) 23400